This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The pharma giant will license drug-delivery technologies from Vivtex to develop next-generation oral medicines for obesity, diabetes and associated diseases. on.wsj.com/4kTbxiF
https://on.wsj.com/4kTbxiF
2026-02-25T13:59:46.761Z